The global market for long-read metagenomics is poised for substantial growth, driven by advancements in sequencing technologies and genomic analytics. According to a recent report added to ResearchAndMarkets.com’s offerings, this market is expected to expand from $1.79 billion in 2025 to $2.16 billion in 2026, reflecting a compound annual growth rate (CAGR) of 21.1%.
Several factors contribute to this growth trajectory, including reduced costs of DNA sequencing and the proliferation of next-generation sequencing platforms. Additionally, there is a significant increase in investments directed towards genomic research programs and the development of metagenomic assembly tools. The rising interest in microbiome analysis further fuels the adoption of long-read sequencing across various sectors, including research, healthcare, and environmental applications.
Looking forward, the market is projected to reach $4.69 billion by 2030, with a CAGR of 21.3%. Key drivers of this growth include the adoption of precision medicine, the expansion of clinical metagenomics diagnostics, and the increasing use of real-time pathogen monitoring systems. There is also a growing demand for portable sequencing solutions, and the integration of artificial intelligence into genomic analytics is expected to enhance data interpretation, workflow efficiency, and sequencing accuracy.
Major trends in the long-read metagenomics market include high-resolution microbial strain identification and advanced error-correction algorithms. Real-time pathogen surveillance using environmental DNA and ultra-deep metagenomic profiling for detecting rare species are also significant trends. Improvements in sample preparation and high-molecular-weight DNA extraction are enhancing the quality and reliability of sequencing results.
The market is further driven by the increasing burden of infectious diseases. The emergence of antimicrobial-resistant pathogens and frequent disease outbreaks necessitate faster and more accurate pathogen detection. Long-read metagenomics plays a crucial role in identifying pathogens, antimicrobial resistance genes, and genomic variations in complex clinical and environmental samples. These capabilities are vital for strengthening disease surveillance, accelerating pathogen characterization, and improving epidemiological monitoring across healthcare and public health systems.
In October 2024, the World Health Organization reported a rise in tuberculosis cases, with 8.2 million new diagnoses in 2023 compared to 7.5 million in 2022. This underscores the need for advanced genomic surveillance technologies to support outbreak response, clinical research, and infectious disease management.
Technology providers are responding to these needs by introducing high-throughput sequencing and genomic analysis solutions designed to automate workflows, improve variant detection, and reduce bioinformatics costs. For instance, in February 2024, PacBio launched the HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for its Revio sequencing system. These solutions facilitate automated sample preparation, greater scalability, shorter workflow times, and lower sequencing costs, supporting complex metagenome assembly and detailed microbial community analysis.
Strategic partnerships are also advancing long-read sequencing applications. In July 2024, Oxford Nanopore Technologies partnered with Plasmidsaurus to expand the use of nanopore-based long-read sequencing in microbial genomics, plasmid analysis, and metagenomic workflows. This collaboration aims to enhance sequencing accuracy, improve scalability, strengthen microbial genome assembly, and accelerate the characterization of complex microbial communities for research and clinical applications.
Regionally, North America led the long-read metagenomics market in 2025, reflecting the region’s established genomic research infrastructure, technology adoption, and investment in precision medicine. The Asia-Pacific region is expected to record rapid growth during the forecast period. The market analysis covers various regions, including Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries included in the analysis are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain. This wide geographical coverage indicates the global interest and investment in long-read metagenomics technologies.
Footnotes:
- The global long-read metagenomics market is projected to grow from $1.79 billion in 2025 to $2.16 billion in 2026. Source.
- The market is expected to reach $4.69 billion by 2030, with a CAGR of 21.3%. Source.
- In October 2024, WHO reported 8.2 million new tuberculosis cases in 2023. Source.
- PacBio launched the HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 in February 2024. Source.
Featured Image: Megapixl @ Fantasista
